EMA articles & resources on Made-in-China.com

Esko Revamps Packaging Management Solution

Nov 17, 2016

WebCenter 16, Esko’s Packaging Management Solution, is an online portal for creating, managing and approving packaging artwork and other assets have been enhanced with a number of across-the-board improvements that bring significant ...

Tags: Esko Revamps Packaging, Packaging

Audi Opens New Automobile Plant in Mexico

Oct 11, 2016

German luxury car-maker Audi is expanding its production footprint worldwide by opening a new automobile plant in San José Chiapa, state of Puebla, Mexico. The plant has an annual production capacity of approximately 150,000 ...

Tags: Audi, automobile plant

ZF Innovation Truck 2016 Sees, Thinks and Acts with Intelligent Driver Assist Systems

Sep 27, 2016

Friedrichshafen/Hanover. Greater safety and improved efficiency through automated driving are mobility megatrends that are increasingly relevant to the commercial vehicle sector. ZF is demonstrating its capabilities in these areas by ...

Tags: ZF Innovation Truck 2016, Intelligent Driver Assist Systems

ZF Enables Commercial Vehicles to See, Think and Act

Sep 27, 2016

Friedrichshafen/Hanover. ZF is further strengthening its position as a major technology supplier for the commercial vehicle industry by providing key technologies for autonomous driving. With these competencies, ZF products can enable ...

Tags: ZF, See–Think–Act

Grocery Manufacturers Association, Bettelle Partner to Combat Food Fraud with EMAlert Tool

Apr 21, 2016

US-based trade organisation the Grocery Manufacturers Association (GMA) and technology company Battelle have partnered to provide a secure, web-based software tool called EMAlert, which allows food manufacturers to review and understand ...

Tags: GMA, Battelle, EMAlert, Food manufactures

Can-Fite Submits Phase III Protocol Design And Registration Plan To EMA For CF101 To Treat Rheumatoid Arthritis

Mar 21, 2016

Can-Fite BioPharma has submitted to the European Medicines Agency (EMA) a protocol design for its Phase III trial and Registration Plan for the Company's lead compound CF101 in the treatment of rheumatoid arthritis following a ...

Tags: Phase III trail, CF101, Can-Fite

LED Siren Tornado Alert System in a U.S. Town Gives Way to Smartphone Alerts

Nov 10, 2015

The Midwest in U.S. is a tornado prone region that many residents in The Heartland have set up weather alerts on their phones to prepare ahead of severe weather, according to WorldNow and KFVS12 report. One town in Missouri has even ...

Tags: LED lighting, tornado sirens, Smartphones

Lightweight Composites Replace More and More Metal Components

Jan 29, 2015

Michelman is introducing a number of new fiber sizings to support advanced generations of engineered resin composites increasingly being used in automotive design and manufacturing applications. As lightweight composites replace more and ...

Tags: thermal resistance, hydrolysis resistance, mechanical performance

BMS Received Breakthrough Therapy Designation for Its Investigational DCV Dual Regimen

Feb 26, 2014

Bristol-Myers Squibb (BMS) has received Breakthrough Therapy Designation from the US Food and Drug Administration (FDA) for its investigational DCV Dual Regimen (daclatasvir and asunaprevir) for use as a combination therapy in the treatment ...

Tags: Bristol-Myers, Medicine

Furiex Announced Top-Line Results Indicating The Two Pivotal Phase III Clinical Trials

Feb 14, 2014

Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced top-line results indicating the company's two pivotal Phase III clinical trials evaluating the efficacy and safety of eluxadoline in the treatment of diarrhea-predominant irritable ...

Tags: Furiex

Teva and Active Biotech Have Announced That Both Companies Remain

Feb 10, 2014

Teva Pharmaceutical Industries and Active Biotech have announced that both companies remain committed to the Nerventra(laquinimod)clinical development program for multiple sclerosis(MS)following the announcement of a negative opinion for ...

Tags: Medicine, clinical studies, Nerventra

CHMP Has Issued a Positive Opinion for The Use of Novartis' Xolair as an Add-on Therapy

Feb 10, 2014

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the use of Novartis’ Xolair (omalizumab) as an add-on therapy for the treatment of chronic spontaneous ...

Tags: Chmp, Chronic Spontaneous Urticaria

CHMP Adopted a Positive Opinion on FINOX Biotech's MAA for BEMFOLA

Feb 7, 2014

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on FINOX Biotech's marketing authorisation application (MAA) for BEMFOLA (follitropin alfa solution for injection in ...

Tags: CHMP, EMA, BEMFOLA, IVF

Monoclonal Antibody Agents Have Been Successfully Used in The Treatment of Tumors

Dec 23, 2013

Currently, monoclonal antibody agents have been successfully used in the treatment of tumors, cancers and other serious diseases as a heavyweight in the biopharmaceutical industry. In 2009-2012, the market size of monoclonal antibody agents ...

Tags: Health, Medicine, Monoclonal Antibody Industry

FDA and EMA Have Announced The Launch of a Joint Initiative to Share Information

Dec 20, 2013

The US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have announced the launch of a joint initiative to share information on inspections of bioequivalence studies submitted in support of generic drug approvals. ...

Tags: Generic Drug, Medicine

EMA

Related Products